On Wednesday March 25, 2020 the House and Senate passed Bill C-13, an emergency federal bill that provides for compulsory licenses for technologies relating to the health emergency on a time limited basis. Other countries have also been considering compulsory licensing options. Lawmakers in Chile and Ecuador have each passed resolutions urging their governments to explore compulsory licensing options. Israel has also permitted companies to produce a generic version of the Kaletra HIV pill owned by AbbVie despite the patent term not expiring until 2024.
NOT LEGAL ADVICE.
Information made available on this website in any form is for information purposes only. It is not, and should not be taken as legal advice. You should not rely on, or take or fail to take any action, based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Oyen Wiggs Green & Mutala LLP professionals will be pleased to discuss resolutions to specific legal concerns you may have.